Senthilnath Lakshmanachetty

11PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 26, 2026
In Vivo CAR-Based Immune Cell Engineering: Future Applications and Challenges in Malignant Glioma.

|Apr 03, 2026
Spike-in probe-enhanced single-cell RNA-seq reveals post-infusion transcriptomic remodeling of "prime-and-kill" synNotch-CAR-T cells.

Takahide Nejo, Payal B Watchmaker, Milos S Simic

|Sep 05, 2025
Differential phagocytosis induces diverse macrophage activation states in malignant gliomas.

Senthilnath Lakshmanachetty, Kent Riemondy, Bridget Sanford

|May 27, 2025
Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma.

Ilango Balakrishnan, Krishna Madhavan, Angela Pierce

|Apr 01, 2025
Differential Phagocytosis induces Diverse Macrophage Activation States in Malignant Gliomas.

Senthilnath Lakshmanachetty, Kent Riemondy, Bridget Sanford

|Feb 17, 2025
SIRT2 Regulates the SMARCB1 Loss-Driven Differentiation Block in ATRT.

Irina Alimova, Dong Wang, John DeSisto

Pageof 2

Frequent Collaborators

4 joint publications

Siddhartha S Mitra

4 joint publications

Hideho Okada

3 joint publications

Sujatha Venkatraman

2 joint publications

Dong Wang